Clinical Trial Update: Study for Patients With Non Small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

This entry provides a Phase 2 clinical trial update for patients with non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: UNKNOWN